ResMed, Inc. Share Price
Stocks
RMD
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 201.30 USD | +1.37% |
|
-3.42% | -16.42% |
| 15/07 | Mizuho Adjusts Price Target on ResMed to $220 From $235, Maintains Outperform Rating | MT |
| 14/07 | Baird Adjusts ResMed Price Target to $217 From $225, Maintains Neutral Rating | MT |
| Market Cap | 2.86TCr 2.5TCr 2.32TCr 2.12TCr 4.02TCr 2,76000Cr 4.09TCr 28TCr 11TCr 1,34800Cr 11TCr 11TCr 4,65300Cr | P/E 2026 * |
18.8x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.78TCr 2.43TCr 2.25TCr 2.06TCr 3.91TCr 2,68200Cr 3.98TCr 27TCr 11TCr 1,31000Cr 10TCr 10TCr 4,52200Cr | EV / Sales 2026 * |
4.93x | EV / Sales 2027 * | 4.47x |
| Free-Float |
75.61% | Yield 2026 * |
1.23% | Yield 2027 * | 1.32% |
Last Transcript: ResMed, Inc.
| 1 day | +1.41% | ||
| 1 week | -3.42% | ||
| Current month | +3.30% | ||
| 1 month | +3.81% | ||
| 3 months | -10.41% | ||
| 6 months | -21.84% | ||
| Current year | -16.42% |
| 1 week | 190.25 | 209.36 | |
| 1 month | 184.65 | 222.43 | |
| Current year | 180.26 | 277.67 | |
| 1 year | 180.26 | 293.81 | |
| 3 years | 132.24 | 293.81 | |
| 5 years | 132.24 | 301.34 | |
| 10 years | 56.59 | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 04/05/2026 |
Jim Ellis
CMP | Compliance Officer | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/07/26 | Fiscal year | Chief Executive Officer | 14,973 | 0.0103% | ||
| 08/06/26 | Fiscal year | Chief Executive Officer | 14,973 | 0.0103% | ||
| 01/06/26 | Tax | General Counsel | -269 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.37% | -3.42% | -20.82% | -8.81% | 2.86TCr | ||
| +0.55% | +2.37% | +29.02% | +2.26% | 20TCr | ||
| +1.02% | +3.45% | +4.88% | -14.73% | 14TCr | ||
| +2.36% | -3.35% | -22.41% | +12.41% | 14TCr | ||
| +3.85% | -0.69% | -56.70% | -15.07% | 6.4TCr | ||
| -0.01% | -4.75% | +14.25% | -6.11% | 5.03TCr | ||
| +1.18% | +2.27% | -23.75% | -31.73% | 4.43TCr | ||
| -0.23% | +0.48% | +18.34% | +13.51% | 3.8TCr | ||
| +0.39% | -0.13% | +30.07% | +39.58% | 3.68TCr | ||
| +1.99% | -0.28% | -14.49% | -20.53% | 2.87TCr | ||
| Average | +1.21% | -1.66% | -4.16% | -2.92% | 7.7TCr | |
| Weighted average by Cap. | +1.25% | -0.27% | +0.27% | -1.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 565.02Cr 493.88Cr 456.74Cr 419.12Cr 793.23Cr 54TCr 807.01Cr 5.45TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr | 610Cr 533.2Cr 493.1Cr 452.48Cr 856.38Cr 59TCr 871.26Cr 5.88TCr 2.31TCr 29TCr 2.29TCr 2.24TCr 99TCr |
| Net income | 154.8Cr 135.31Cr 125.13Cr 114.82Cr 217.32Cr 15TCr 221.1Cr 1.49TCr 586.23Cr 7.28TCr 581.32Cr 568.55Cr 25TCr | 170.74Cr 149.24Cr 138.02Cr 126.65Cr 239.7Cr 16TCr 243.87Cr 1.65TCr 646.61Cr 8.03TCr 641.2Cr 627.11Cr 28TCr |
| Net Debt | -80Cr -70Cr -65Cr -60Cr -112.85Cr -7.75TCr -114.81Cr -774.95Cr -304.43Cr -3.78TCr -301.88Cr -295.25Cr -13TCr | -139.65Cr -122.07Cr -112.89Cr -103.59Cr -196.05Cr -13TCr -199.46Cr -1.35TCr -528.86Cr -6.57TCr -524.43Cr -512.91Cr -23TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | $201.32 | +1.38% | 4,50,952 |
| 15/26/15 | $198.57 | +2.88% | 12,08,785 |
| 14/26/14 | $193.01 | -2.77% | 16,22,359 |
| 13/26/13 | $198.50 | -2.63% | 21,61,420 |
| 10/26/10 | $203.87 | -2.20% | 13,31,149 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions

















